Who owns USANA HEALTH SCIENCES INC (USNA)? Elite investor 13F holders
3 tracked elite investors reported holding USANA HEALTH SCIENCES INC as of 2026-06-30, including Pzena Investment Management, Renaissance Technologies LLC, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health;…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Pzena Investment Management | USANA HEALTH SCIENCES INC | SHARE | 2026-06-30 | 2026-08-07 00:00:00 | 25739282.00 USD | 1205587.000000 | Shares | add | Original filing |
| Renaissance Technologies LLC | USANA HEALTH SCIENCES INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 20464402.00 USD | 958520.000000 | Shares | reduce | Original filing |
| D.E. Shaw | USANA HEALTH SCIENCES INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3348427.00 USD | 156835.000000 | Shares | reduce | Original filing |
| Tudor Investment | USANA HEALTH SCIENCES INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.